This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
ChemoCentryx nets $48.1mm in initial public offering
05 Mar 2012
Just over three years after withdrawing an S-1 due to market conditions, ChemoCentryx Inc. (therapeutics targeting the chemokine system) has finally gone public. The company netted $48.1mm by selling 5.2mm shares (including the overallotment) at $10. Last month it had planned to offer slightly fewer shares (4mm), but at a higher range, $14-16.
Drug Discovery Tools
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?